Total synthesis of (-)-4,8,10-tridesmethyl telithromycin.

Total synthesis of (-)-4,8,10-tridesmethyl telithromycin.
复制标题

DOI:
10.1021/jo201319b
复制
发表时间:
2011-09-16
影响因子:
3.6
通讯作者:
Andrade, Rodrigo B.
Andrade, Rodrigo B.
中科院分区:
化学2区
文献类型:
--
作者:
Velvadapu, Venkata;Paul, Tapas;Wagh, Bharat;Glassford, Ian;DeBrosse, Charles;Andrade, Rodrigo B.

文献摘要

参考文献

被引文献

相似文献

需要新的抗生素来源来解决抗生素耐药性的严重问题。泰利霉素 (2) 是由红霉素 (1) 制备的第三代大环内酯类抗生素,自 2004 年起用于临床。在此,我们报告了我们的努力细节,最终实现了 (−)-4,8,10-tridesmethyl 泰利霉素 (3) 的全合成,其中甲基已被氢取代。去甲基大环内酯的合成已成为制备生物活性抗生素的新策略。
Novel sources of antibiotics are required to address the serious problem of antibiotic resistance. Telithromycin (2) is a third-generation macrolide antibiotic prepared from erythromycin (1) and used clinically since 2004. Herein we report the details of our efforts that ultimately led to the total synthesis of (−)-4,8,10-tridesmethyl telithromycin (3) wherein methyl groups have been replaced with hydrogens. The synthesis of desmethyl macrolides has emerged as a novel strategy for preparing bioactive antibiotics.
DOI: 10.1021/jo00360a058
发表时间: 1986-05-16
影响因子: 3.6
作者:
HANSON, RM;SHARPLESS, KB
通讯作者: SHARPLESS, KB
DOI: 10.1002/anie.200351136
发表时间: 2003-01-01
影响因子: 16.6
作者:
Hergenrother, PJ;Hodgson, A;Martin, SF
通讯作者: Martin, SF
DOI: 10.1021/ja00706a074
发表时间: 1970-01-01
影响因子: 15
作者:
JOHNSON, WS;WERTHEMANN, L;PETERSEN, MR
通讯作者: PETERSEN, MR
DOI: 10.1021/jo062047u
发表时间: 2006-12-22
影响因子: 3.6
作者:
Venkatraman, Lakshmanan;Salomon, Christine E.;Fecik, Robert A.
通讯作者: Fecik, Robert A.
DOI: 10.1021/ja01592a069
发表时间: 1956-01-01
影响因子: 15
作者:
DAUBEN, WG;FONKEN, GJ;NOYCE, DS
通讯作者: NOYCE, DS